Abstract
INTRODUCTION
Helicobacter pylori (H. pylori) has been classified as a class Ⅰ carcinogen by the International Agency for Research on Cancer [1] . H. pylori can live in the acidic environment of the stomach for a long time, and its prolonged infection can destroy the gastric mucosa and result in changes in the release of gastric mucosal hormones, thus affecting the physiological state of the stomach. Therefore, H. pylori infection represents the most significant risk factor for malignant gastric tumours [2, 3] . Approximately 50% of the world's population are infected with H. pylori [4, 5] . The infection rate in China may be as high as 73.3% [6] , especially in the Beijing region, where the infection rate is as high as 83.4% [7] . Although there have been increasing numbers of studies indicating that H. pylori infection can result in gastric cancer (GC), the underlying mechanism is still unknown.
Heparanase (HPA) is an endoglycosidase that is capable of degrading heparan sulfate (HS) in the extracellular matrix (ECM) and basement membrane (BM) [8, 9] , the process of which releases many types of biological mediators, such as fibroblast growth factor (FGF), hepatocyte growth factor (HGF), and vascular endothelial growth factor (VEGF), in response to local or systemic signals [10, 11] . Thus, HPA is involved in tissue remodelling and cell migration, which lead to inflammation, angiogenesis, and tumour metastasis [12] [13] [14] [15] . The degradation of the ECM is one of the key steps involved in the invasion and metastasis of malignant tumours, and matrix degradation primarily depends on proteolytic enzymes. An increasing number of studies have demonstrated that the invasion and metastasis of tumour cells are closely associated with HPA production [16] [17] [18] , including those derived from the stomach, pancreas, colon, and bladder. In addition to its enzymatic activity, recent studies have shown that the non-enzyme activity of HPA promotes the aggregation of heparan sulfate proteoglycans (HSPGs), causing a cascade of intracellular signal amplification that results in the activation of protein kinase C (PKC), Src, and Rac. HSPGs act on HPA receptors located on the cell surface, such as 6-phosphate mannose receptor (MPR), cationic non-6-phosphate-dependent mannose receptor (CD222), and low-density lipoprotein receptor-related protein (LRP), to cause signalling cascades. In addition, HPA plays an important role in inflammation and autoimmune diseases (e.g., colitis, arthritis, psoriasis, and sepsis) [19, 20] . Some studies have shown that H. pylori infection leads the development of gastric adenocarcinoma by activating mitogen-activated protein kinase (MAPK) [21, 22] . Once activated, MAPK is translocated to the nucleus and leads to the activation of transcription factors, such as NF-κB [23, 24] . A recent study [25] has also shown that the activation of the MAPK pathway is closely related to the expression of HPA. However, it is not clear whether MAPK is involved in the regulation of HPA expression following H. pylori infections that lead to GC. The present research aimed to explore the role of H. 
MATERIALS AND METHODS

Cells and H. pylori strain
Infection of MKN-45 cells with H. pylori
After digestion, MKN-45 cells were inoculated in three culture dishes with an equal cell volume and cultured under normal growth conditions until they reached the logarithmic growth phase, at which point the old medium was discarded and replaced with culture medium containing serum and antibiotics. H. pylori was cultured at 37 ℃ for 72 h under microaerophilic conditions using an anaerobic box. H. pylori was then added to the above cell medium at a bacteria:cell ratio of 100:1. The bacteria and cells were co-cultured for 6, 12, 24, and 48 h at 37 ℃ in 5% CO2 and saturated humidity to detect HPA and MAPK expression.
Western blot assay
Total protein of the treated cells was extracted using RIPA lysis buffer (Beyotime Biotechnology, Haimen, China), phenylmethanesulfonyl fluoride (PMSF) (Beyotime Biotechnology), and a protein phosphatase inhibitor (Solarbio Biotechnology Co., Shanghai, China) after being washed with ice-cold phosphate-buffered saline (PBS). The protein concentration was measured by the BCA protein assay (Beyotime Biotechnology) after centrifugation at 14000 rpm for 30 min. The protein was separated on a 10% SDS polyacrylamide gel and then transferred onto a polyvinylidene fluoride (PVDF) membrane (Solarbio Biotechnology), which was then blocked in the blocking solution for 2 h at a constant temperature. Then, the above membrane was incubated with the following primary antibodies: anti-heparanase1 (Abcam Biotechnology, Cambridge, United Kingdom), anti-phospho-p38, anti-p38 (Abcam Biotechnology), and anti-β-actin (Zhongshan Golden Bridge Biotech, Beijing, China). After overnight incubation, the membrane was washed three times with Tris Buffered Saline-Tween (TBST) (Solarbio Biotechnology) and then incubated with a horseradish peroxidase-conjugated secondary antibody (Zhongshan Golden Bridge Biotech; dilution 1:10000) at room temperature for 1 h. The SuperSignal West Pico Chemiluminescent Substrate (ThermoFisher Scientific, Inc., Rockford, IL, United States) was used to detect signals, which were displayed with a VersaDoc Imaging System (Bio-Rad Laboratories Co., Ltd. Hercules, CA, United States). Data were analysed using Bio-Rad Quantity One Software v4.62 (Bio-Rad Laboratories Co., Ltd.). To further illustrate whether the H. pylori-induced upregulation of HPA was mediated through the MAPK pathway, 20 μmol/L of the MAPK inhibitor SB203580 (Selleck, United States) was added to MKN-45 cells for 2 h before they were cultured with H. pylori.
Transwell assay
A Transwell assay was used to detect the invasion capability of the tumour cells. A 1:8 mixture of Matrigel gel:RPMI-1640 medium (100 μL) was added to the lower chamber, which was placed in 24-well plates at 37 ℃ for 24 h. A serum-free cell suspension (200 μL) at a concentration of 2.5 × 10 5 cells/mL was added to the upper chamber, while serum-containing medium was added to the lower chamber. Then, the cells were cultured at 37 ℃ in an atmosphere with 5% CO2 and saturated humidity for 24 h. The remaining cells in the upper chamber were carefully wiped off, and the lower chamber was rinsed twice with PBS and fixed in methanol for 15 min. The cells were stained with crystal violet solution in methanol for 30 min, and then excess crystal violet was washed off. The cells were observed and images were obtained using a microscope. The number of migrated cells was counted in several fields of view.
Scratch test
The scratch test was used to detect the migration ability of tumour cells. Horizontal lines were drawn every 0.5-1 cm on the back of a 6-well plate and 5 × 10 5 cells were added to each well. The cells were incubated overnight and when cells were 100% confluent, a cut was made across the dish with a 200-mL pipette. The cells were rinsed twice with PBS, serum-free medium was added, and the cells were incubated at 37 ℃ in an atmosphere with 5% CO2. Following the incubation, images of the cells were obtained and the migration distance was measured.
Patients and clinicopathological characteristics
Ninety-nine cases of pathologically diagnosed and surgically resected primary gastric carcinoma tissues and prepared for antigen retrieval with citrate by the high-temperature and high-pressure method. Primary antibodies were added to the sections and incubated at 37 ℃ in the dark for 1 h. Then, secondary antibodies were added for 30 min. Next, DAB chromogenic reagent was added to develop and hematoxylin was added to stain. The working concentrations of the primary antibodies against HPA and MAPK were both 1:200, and the negative control group used PBS instead of the primary antibody. Positive staining for HPA and MAPK was both primarily located in the cytoplasm. The semiquantitative scoring criteria were as follows: according to the percentage of positive cells and staining intensity of each slice, the positive staining cell ratio was recorded as 0 points, 1 point, 2 points and 3 points for < 5%, 5% to 25%, 26% to 50%, and > 50%, respectively; the staining intensity was defined as 0 points, 1 point, 2 points and 3 points for no staining, pale yellow, brownish yellow and tan, respectively. 
H. pylori infection status
Statistical analysis
Data were analysed using SPSS 22.0 statistical software (IBM, Amonk, NY, United States). The classified data are described as the number of cases and rate or constituent ratio (% regression analyses were used to explore the influencing factors of the survival time. P < 0.05 was considered statistically significant.
RESULTS
HPA and MAPK protein expression in GC tissue is higher than that in para-carcinoma tissue and normal gastric tissue
To detect HPA and MAPK protein expression in GC, immunohistochemical staining was carried out. Representative results from the immunohistochemical staining are shown in Figure 1 and detailed data are shown in Table 1 . As shown in Figure 1 , HPA and MAPK were not basally expressed in normal gastric tissue and were seldom expressed in para-carcinoma tissue; however, expression of HPA and MAPK was significantly positive in GC tissue. As seen in Table 1 , HPA and MAPK were not basally expressed in normal gastric tissue, but expression of HPA and MAPK was positive in GC and para-carcinoma tissues, and expression of HPA and MAPK in GC tissue was significantly higher than that in para-carcinoma and normal tissues.
H. pylori infection in GC is relevant to the expression of HPA and MAPK and leads to higher expression than that in normal gastric tissue
To detect the H. pylori infection levels, the clinical C13 exhalation test and immunohistochemical staining of surgical sections were used. There were 70 cases of H. pylori infection out of 99 GC cases, with a positive rate of 70.71%, and 10 cases of H. pylori infection out of 25 healthy control cases, with a positive rate of 40.0%.
There was a significant difference between the levels of H. pylori infection in GC and those of normal gastric tissue (P < 0.05), as revealed in Table 2 . This result suggests that there is a significant correlation between H. pylori infection and GC.
Correlation between H. pylori infection, expression of HPA and MAPK proteins, and pathological characteristics of GC
To ascertain the effects of H. pylori infection and HPA and MAPK protein expression in GC, the associations among the clinical pathological characteristics of gastric cancer and the above factors were analysed. Positive H. pylori infection and positive expression of HPA were both associated with lymph node metastasis (P < 0.05), but not with age, gender, diameter of tumour, or differentiation degree (P > 0.05). Similarly, positive HPA expression and positive MAPK expression were both associated with the depth of invasion (P < 0.05), as shown in Table 3 . There were 54 cases of HPA positive expression in 70 H. pylori positive GC cases, with a positive rate of 54.5%, and 15 cases of HPA positive expression in 29 H. pylori negative GC cases, with a positive rate of 15.2%. Obviously, significantly higher levels of HPA positive expression in H. pylori positive GC cases were observed than those in H. pylori negative GC cases (P < 0.05), as shown in Table 4 . This result suggests that there is significant HPA expression in GC with H. pylori infection.
There were 40 cases with MAPK positive expression in 70 H. pylori positive GC cases, with a positive rate of 40.4%, and 10 cases of MAPK positive expression in 29 H. pylori negative GC cases, with a positive rate of 10.1%. Significantly higher levels of MAPK positive expression in H. pylori positive GC cases were observed than those in H. pylori negative GC cases (P < 0.05), as shown in Table 5 .
There were 40 cases of MAPK positive expression in 69 HPA positive GC cases, with a positive rate of 39.4%, and 10 cases of MAPK positive expression in 30 HPA negative GC cases, with a positive rate of 11.1%. Significantly higher MAPK positive expression in HPA positive GC cases were observed than those in HPA negative GC cases (P < 0.05), as shown in Table 6 . This result suggests that there is a significant correlation between HPA expression and MAPK expression in GC. 
H. pylori infection, HPA, and prognosis
HPA positive expression in GC significantly predicted poor overall survival (P = 0.000) and poor relapse-free survival (P = 0.006). Especially in H. pylori-infected GC, HPA positive expression was a more significant factor for predicting poor prognosis (overall survival, P = 0.000; relapse-free survival, P = 0.007) (Figure 3 ).
H. pylori infection, MAPK, and prognosis
MAPK positive expression in GC cannot predict overall survival (P = 0.063) or relapse-free survival (P = 0.163). However, in H. pylori-infected GCs, MAPK positive expression was a relatively significant factor for predicting poor prognosis (overall survival, P = 0.007), but did not predict relapse-free survival (P = 0.557) (Figure 4 ).
Prognostic analysis using the COX regression model
Univariate COX regression analysis: By applying the COX regression model to single factor prognostic analysis, a stepwise regression approach was used. The results showed that there was no correlation between gender, age, and tumour diameter. However, lymph node metastasis in GC patients had a significant influence on prognosis (P = 0.003). The degree of histological differentiation had a positive impact on the prognosis of patients with GC (P = 0.003); the tumour invasion depth was also significantly associated with the prognosis of GC patients (P = 0.015). The level of HPA expression also had a very important role in the prognosis of GC patients (P = 0.000), and MAPK expression also had an influence on the prognosis of GC patients (P = 0.031). Whether H. pylori infection was present in patients with GC had no correlation with prognosis (P = 0.849), but H. pylori infection may play an important role in the initiation of GC. Therefore, the univariate COX regression analysis showed that lymph node metastasis, tissue differentiation, depth of invasion, and HPA expression in GC tissues were significantly correlated with the prognosis of patients (Table 7) .
Multivariate COX regression analysis:
The COX regression multivariate model was used for analysis. The results showed that age, sex, tumour diameter, MAPK expression, and H. pylori infection were all removed from the model and that lymph node metastasis, tissue differentiation, depth of invasion, and HPA expression were independent prognostic factors that affected the overall survival rate of GC patients. The relative risk of lymph node metastasis in GC tissues [hazard ratio (HR) = 4.443, P = 0.000] indicated that there was a higher risk of death (increased by 6.52 times) in GC patients with lymph node metastasis compared with those without. The lower the tissue differentiation of patients with GC, the higher the risk of death (HR = 3.452, P = 0.013). The greater the invasion of GC, the higher the risk of death [risk ratio (RR) = 2.542, P = 0.015]. The higher the expression of HPA protein in GC tissues, the shorter the survival time of patients (RR = 2.463, P = 0.015) (Table 8) 
DISCUSSION
HPA has been documented in many primary human tumours [26] [27] [28] , including GC [29] , and is known to have multiple vital functions in accelerating tumour growth, angiogenesis, and tumour metastasis [30] [31] [32] . MAPK, including JNK, ERK, and p38 kinase, plays pivotal roles in proliferation, invasion, and migration of cancer cells [33] [34] [35] [36] . There are many studies [37] [38] [39] that have shown that H.
pylori infection leads to increased p38MAPK in GC cells, and it has also been shown [40] that p38MAPK leads to HPA elevation. This study showed that HPA and MAPK expression was significantly higher in patients with GC than that in para-carcinoma and normal gastric tissues. Our research also confirmed that HPA was highly expressed in GC cells, as has been previously reported in the literature [41, 42] . To explain the correlation between HPA and MAPK expression and the clinical pathology of GC cases, we first investigated the clinicopathological characteristics. Positive expression of HPA was associated with lymph node metastasis and depth of invasion, but not with age, gender, tumour diameter, or differentiation degree. In addition, positive MAPK expression was only associated with depth of invasion, which illustrates that HPA is involved in the invasion and metastasis of GC and that MAPK is primarily involved in the proliferation of GC cells. This research also suggests that there is a significant correlation between HPA expression and MAPK expression in GC.
H. pylori, as a class Ⅰ carcinogen, causes invasion, proliferation, and metastasis of GC cells [43, 44] , but its specific mechanism of action remains unclear. It has been reported [45, 46] that infections can cause a HPA elevation. H. pylori, as a bacterium, is associated with various human gastric diseases, especially gastritis and GC, but there has been no evaluation of whether H. pylori infection causes an increase in HPA in GC, which would contribute to the invasion and metastasis of GC. In the present study, it was revealed that H. pylori infection is significantly associated with HPA expression and that a positive H. pylori infection is connected to lymph node metastasis. To further elucidate the effect of H. pylori infection leading to heparanase elevation in GC, MKN-45 GC cells were infected by H. pylori. We showed that HPA expression was the highest at 24 h post H. pylori infection in these GC cells and the abilities of invasion and metastasis were increased when GC cells were infected by H. pylori.
There are many studies [37] [38] [39] showing that H. pylori infection leads to increased p38MAPK in GC cells, and it has been shown that [40] p38MAPK leads to elevation of HPA expression is a poor prognostic factor in some cancers [47] [48] [49] , including GC [50, 51] . In the present study, it was revealed that positive expression of HPA was able to predict the malignancy of GC due to its correlation with lymphatic metastasis and invasive depth. Beyond that, positive expression of HPA was a poor prognostic factor for overall survival and relapse-free survival compared with HPA negative cases, which was consistent with previously published reports [52] . Especially in GC patients with an obvious H. pylori infection, HPA positive expression indicated a poorer prognosis both in overall survival and in relapse-free survival, which illustrates that HPA is an important factor for the prediction of prognosis and relapse of GC and that H. pylori infection leads to an increase of HPA expression, which can worsen the prognosis of GC and make recurrence more likely. Compared to HPA, positive MAPK expression only predicted prognosis in overall survival of GC patients, which was consistent with previous reports [53] , but MAPK expression could not predict a relapse in H. pylori-infected GC. Thus, MAPK expression cannot be used to determine the prognosis of GC patients with H. pylori infection, but a poor prognosis of GC patients with positive HPA expression is associated with H. pylori positive cases, which suggests that therapy against HPA should be taken into account when GC patients are infected with H. pylori.
Univariate COX regression analysis showed that lymph node metastasis, degree of histological differentiation, and invasive depth in GC patients had a significant influence on prognosis, which was identical to the results of previously published reports [54] . Moreover, in the univariate COX regression analysis, the levels of HPA and MAPK expression also had an influence on the prognosis of GC patients. Similarly, multivariate COX regression analysis showed that lymph node metastasis, tissue differentiation, depth of invasion, and HPA protein expression level were independent prognostic factors that affected the overall survival rate of GC patients. In addition to using the clinical characteristics to judge prognosis, such as lymph node metastasis, tissue differentiation, and depth of invasion, HPA is still an important factor as a biomarker to judge the prognosis of GC, which is consistent with the report by Takaoka et al [51] .
In conclusion, the results of the current study demonstrate that H. pylori infection is not only the primary factor Relapse-free survival involved in GC but is also involved in the invasion and metastasis of GC by upregulating HPA expression, which is likely mediated via activation of the MAPK signalling pathway. HPA is an important factor for predicting the prognosis and relapse of GC, and H. pylori infection increases HPA expression, which makes the prognosis of GC more aggressive and recurrence more likely, suggesting that therapy against HPA should be taken into consideration when GC patients are infected with H. pylori.
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